The Yale-Griffin Prevention Research Center is one of the Centers for Disease Control's 26 Prevention Research Centers. It was established in 1998 with a grant from the CDC. It is part of the Yale School of Public Health, and is based at Griffin Hospital in Derby, Connecticut.

During the past decade, Yale-Griffin Prevention Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale-Griffin Prevention Research Center" #1 collaborator was "American Egg Board" with 1 trials as a collaborator, "California Walnut Commission" with 1 trials as a collaborator, "Fos Biomedical" with 1 trials as a collaborator, "ISOThrive Inc." with 1 trials as a collaborator and "Kind LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Yale-Griffin Prevention Research Center" are "Cardiovascular Diseases" (3 trials), "Obesity" (3 trials), "Type 2 Diabetes" (3 trials), "Diabetes" (1 trials) and "Fibromyalgia" (1 trials). Many other conditions were trialed in "Yale-Griffin Prevention Research Center" in a lesser frequency.

Most popular intervention types in "Yale-Griffin Prevention Research Center" are "Dietary Supplement" (7 trials), "Device" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AngioDefender" (1 trials), "Brachial artery ultrasound imaging" (1 trials), "Chromium" (1 trials), "Egg exclusion" (1 trials) and "Egg included vegan phase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale-Griffin Prevention Research Center" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yale-Griffin Prevention Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Yale-Griffin Prevention Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale-Griffin Prevention Research Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".